Cover Image
市場調查報告書

糖尿病護理設備市場:產品 - 全球機會分析及產業預測

Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023

出版商 Allied Market Research 商品編碼 563355
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
糖尿病護理設備市場:產品 - 全球機會分析及產業預測 Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023
出版日期: 2017年08月01日 內容資訊: 英文 120 Pages
簡介

本報告提供全球糖尿病護理設備市場相關調查,市場的各產品、各地區的趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 市場佔有率分析
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 影響分析
  • 臨床實驗

第4章 各產品市場

  • 概要
  • 血糖監測系統設備
    • 自我監測血糖儀表
    • 採血針
    • 持續的血糖監測儀
  • 胰島素遞輸設備
    • 胰島素注射器
    • 胰島素筆針
    • 胰島素幫浦
    • 胰島素噴射注射器

第5章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第6章 企業簡介

目錄
Product Code: LI 172842

The global diabetes care devices market was valued at $6,867 million in 2016, and is growing at a CAGR of 5.8% from 2017 to 2023 to reach $10,208 million by 2023. Diabetes care devices are used to check the blood glucose or the insulin level in a patient's body.

The major factor that contributes to the growth of the diabetes care devices market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth. In addition, rise in awareness about diabetes monitoring devices, and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.

Diabetes care devices market is segmented on the basis of type and region. Based on type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices are categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. Insulin delivery devices segment is further divided into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

BY PRODUCT

  • Blood Glucose Monitoring Devices
  • Testing Strips
  • Self-monitoring Blood Glucose Meters
  • Lancets
  • Continuous Blood Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors

BY REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG)
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic plc
  • Novo Nordisk A/S
  • Terumo Corporation
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • Arkray, Inc.
  • Echo Therapeutics, Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Sanofi
  • Ypsomed AG

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
      • 3.2.2.1. Competitive intelligence of companies and their strategies
  • 3.3. MARKET SHARE ANALYSIS, 2016
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Impact analysis
  • 3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. BLOOD GLUCOSE MONITORING DEVICES
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size and forecast
    • 4.2.4. Testing Strips
      • 4.2.4.1. Market size and forecast
    • 4.2.5. Self-monitoring Blood Glucose Meters
      • 4.2.5.1. Market size and forecast
    • 4.2.6. Lancets
      • 4.2.6.1. Market size and forecast
    • 4.2.7. Continuous Glucose Monitors
      • 4.2.7.1. Market size and forecast
  • 4.3. INSULIN DELIVERY DEVICES
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size and forecast
    • 4.3.4. Insulin Syringes
      • 4.3.4.1. Market size and forecast
    • 4.3.5. Insulin Pens
      • 4.3.5.1. Market size and forecast
    • 4.3.6. Insulin Pumps
      • 4.3.6.1. Market size and forecast
    • 4.3.7. Insulin Jet Injectors
      • 4.3.7.1. Market size and forecast

CHAPTER 5 DIABETES CARE DEVICES MARKET, BY REGION

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. NORTH AMERICA
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
    • 5.2.4. U.S.
    • 5.2.5. Canada
    • 5.2.6. Mexico
  • 5.3. EUROPE
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast
    • 5.3.4. Germany
    • 5.3.5. France
    • 5.3.6. UK
    • 5.3.7. Italy
    • 5.3.8. Spain
    • 5.3.9. Rest of Europe
  • 5.4. ASIA-PACIFIC
    • 5.4.1. Key market trends
    • 5.4.2. Key growth factors and opportunities
    • 5.4.3. Market size and forecast
    • 5.4.4. Japan
    • 5.4.5. China
    • 5.4.6. India
    • 5.4.7. Australia
    • 5.4.8. South Korea
    • 5.4.9. Rest of Asia-Pacific
  • 5.5. LAMEA
    • 5.5.1. Key market trends
    • 5.5.2. Key growth factors and opportunities
    • 5.5.3. Market size and forecast
    • 5.5.4. Brazil
    • 5.5.5. South Africa
    • 5.5.6. Saudi Arabia
    • 5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

  • 6.1. ABBOTT LABORATORIES
    • 6.1.1. Company overview
    • 6.1.2. Operating business segments
    • 6.1.3. Business performance
    • 6.1.4. Key strategic moves and developments
  • 6.2. ACON LABORATORIES, INC.
    • 6.2.1. Company overview
    • 6.2.2. Operating business segments
    • 6.2.3. Business performance
    • 6.2.4. Key strategic moves and developments
  • 6.3. ASCENSIA DIABETES CARE HOLDINGS AG
    • 6.3.1. Company overview
    • 6.3.2. Operating business segments
    • 6.3.3. Key strategic moves and developments
  • 6.4. BECTON, DICKINSON AND COMPANY
    • 6.4.1. Company overview
    • 6.4.2. Operating business segments
    • 6.4.3. Business performance
    • 6.4.4. Key strategic moves and developments
  • 6.5. DEXCOM, INC.
    • 6.5.1. Company overview
    • 6.5.2. Operating business segments
    • 6.5.3. Business performance
    • 6.5.4. Key strategic moves and developments
  • 6.6. F. HOFFMANN-LA ROCHE LTD.
    • 6.6.1. Company overview
    • 6.6.2. Operating business segments
    • 6.6.3. Business performance
    • 6.6.4. Key strategic moves and developments
  • 6.7. JOHNSON & JOHNSON
    • 6.7.1. Company overview
    • 6.7.2. Operating business segments
    • 6.7.3. Business performance
    • 6.7.4. Key strategic moves and developments
  • 6.8. MEDTRONIC PLC
    • 6.8.1. Company overview
    • 6.8.2. Operating business segments
    • 6.8.3. Business performance
    • 6.8.4. Key strategic moves and developments
  • 6.9. NOVO NORDISK A/S
    • 6.9.1. Company overview
    • 6.9.2. Operating business segments
    • 6.9.3. Business performance
    • 6.9.4. Key strategic moves and developments
  • 6.10. TERUMO CORPORATION
    • 6.10.1. Company overview
    • 6.10.2. Operating business segments
    • 6.10.3. Business performance
    • 6.10.4. Key strategic moves and developments
Back to Top